Journey from cachexia to obesity by TNF

FASEB Journal

Volumn 11, Issue 10, 1997, Pages 743-751

  Argilés, Josep M ^a   López Soriano, Joaquín ^a   Busquets, Sílvia ^a   López Soriano, Francisco J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Adipose tissue; Diabetes; Insulin resistance; Thermogenesis adipostat

Indexed keywords

ADIPSIN; GLUCOSE TRANSPORTER; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; BODY MASS; BODY WEIGHT; CACHEXIA; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; THERMOGENESIS;

RODENTIA;

EID: 0343742637     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.11.10.9271359     Document Type: Review

References (107)

1. Coley, W. B. (1893) The treatment of malignant tumours by repeated inoculations of erysipelas; with a report often original cases. Am. J. Med. Sci. 105, 487-511
2. Old, L. J. (1985) Tumor necrosis factor (TNF). Science 230, 630-632
3. Kawakami, M., and Cerami, A. (1981) Studies of endotoxin-induced decrease in lipoprotein lipase activity. J. Exp. Med. 154, 631-637
4. Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y. C., Mathison, J., Ulevitch, R., and Cerami, A. (1985) Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature (London) 316, 552-554
5. Jue, D. M., Sherry, B., Luedke, C., Manogue, K. R., and Cerami, A. (1990) Processing of newly synthesized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages. Biochemistry 29, 8371-8377
6. Aggarwal, B. B., and Natarajan, K. (1996) Tumor necrosis factors: developments during last decade. Eur. Cytokine Netw. 7, 93-124
7. Lawson, D. H., Richmond, A., Nixon, D. W., and Rudman, D. (1982) Metabolic approach to cancer cachexia. Annu. Rev. Nutr. 2, 277-301
8. Argilés, J. M., and Azcón-Bieto, J. (1988) The metabolic environment of cancer. Mol. Cell. Biochem. 81, 3-17
9. Ogiwara, H., Takahashi, S., Kato, Y., Uyama, I., Takahara, T., Kikuchi, K., and Iida, S. (1994) Diminished visceral adipose tissue in cancer cachexia. J. Surg. Oncol. 57, 129-133
10. Morrison, S. D. (1989) Cancer cachexia. In: Influence of tumor development on the host (Liotta, A. L., ed) pp. 176-213, Kluwer Acad. Publ., Amsterdam
11. Scuderi, P., Lam, K. S., Ryan, K. J., Petersen, E., Sterling, K. E., Finley, P. R., Ray, C. G., Slymen, D. J., and Salmon, S. E. (1986) Raised serum levels of tumour necrosis factor in parasitic infections. Lancet 2, 1364-1365
12. Grau, G. E., Fajardo, L. F., Piguet, P. F., Allet, B., Lambert, P. H., and Vassalli, P. (1987) Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237, 1210-1212
13. Waage, A., Espevik, T., and Lamvik, J. (1986) Detection of tumor necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients. Scand. J. Immunol. 24, 739-743
14. Beutler, B., Milsark, I. V., and Cerami, A. (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 869-871
15. Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., and Cerami, A. (1987) Anticachectin/ TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (London) 330, 662-664
16. Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., and Wilmore, D. W. (1988) Detection of circulating tumor necrosis factor after endotoxin administration. New Engl. J. Med. 318, 1481-1486
17. Balkwill, F., Burke, F., Talbot, D., Tavernier, J., Osborne, R., Naylor, S., Durbin, H., and Fiers, W. (1987) Evidence for tumour necrosis factor/cachectin production in cancer. Lancet 2, 1229-1232
18. Saarinen, U. M., Kosfelo, E. K., Teppo, A. M., and Simes, M. A. (1990) Tumor necrosis factor in children with malignancies. Cancer Res. 50, 592-595
19. Moldawer, L. L., Drott, C., and Lundholm, K. (1988) Monocytic production and plasma bioactivities of interleukin-1 and tumour necrosis factor in human cancer. Eur. J. Clin. Invest. 18, 486-492
20. Socher, S. H., Martinez, D., Craig, J. B., Kuhn, J. G., and Oliff, A. (1988) Tumour necrosis factor nondetectable in patients with cancer cachexia. J. Natl. Cancer Inst. 80, 595-598
21. Selby, P. J., Hobbs, S., Niner, C., Jackson, E., Smith, I. E., and McElwain, T. J. (1988) Endogenous tumour necrosis factor in cancer patients. Lancet 1, 483
22. Stovroff, M. C., Fraker, D. L., and Norton, J. A. (1988) Cachectin activity in the serum of cachectic, tumor-bearing rats. Arch. Surg. 124, 94-99
23. Costelli, P., Carbó, N., Tessitore, L., Bagby, G. J., López-Soriano, F. J., Argilés, J. M., and Baccino, F. M. (1993) Tumour necrosis factor-α mediates changes in muscle protein turnover in a cachectic rat tumour model. J. Clin. Invest. 92, 2783-2789
24. Aderka, D., Fischer, D., Levo, Y., Holtmann, H., Hahn, T., and Wallach, D. (1985) Cachectin/tumour necrosis factor production by cancer patients. Lancet 2, 1190
25. Price, S. R., Olivecrona, T., and Pekala, P. H. (1986) Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor: the primary regulatory role of the hormone in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 251, 738-746
26. Cornelius, P., Enerback, S., Bjursell, G., Olivecrona, T., and Pekala, P. H. (1988) Regulation of lipoprotein lipase mRNA content in 3T3-L1 cells by tumour necrosis factor. Biochem. J. 249, 765-769
27. Fried, S. K., and Zechner, R. (1989) Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity. J. Lipid Res. 30, 1917-1923
28. Semb, H., Peterson, J., Tavernier, J., and Olivecrona, T. (1987) Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J. Biol. Chem. 262, 8390-8394
29. 14C]lipid load in virgin, lactating and litter-removed rats. Biochem. J. 256, 1055-1058
30. Feingold, K. R., and Grunfeld, G. (1987) Tumor necrosis factor-α stimulates hepatic lipogenesis in the rat in vivo. J. Clin. Invest. 80, 1384-1389
31. Krauss, R. M., Grunfeld, C., Doerrler, W. T., and Feingold, K. R. (1990) Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition. Endocrinology 127, 1016-1021
32. Kern, P. A. (1988) Recombinant human tumor necrosis factor does not inhibit lipoprotein lipase in primary cultures of isolated human adipocytes. J. Lipid R329, 909-914
33. Kawakami, M., Murase, T., Ogawa, H., Ishibashi, S., Mori, N., Takaku, F., and Shibata, S. (1987) Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. J. Biochem. 101, 331-338
34. Feingold, K. R., Doerrler, W., Dinarello, C. A., Fiers, W., and Grunfeld, C. (1992) Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and interferons is blocked by inhibition of prostaglandins synthesis. Endocrinology 130, 10-16
35. Hauner, H., Petruschke, T., Russ, M., Röhrig, K., and Eckel, J. (1995) Effects of tumour necrosis factor-alpha (TNFα) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 38, 764-771
36. Pape, M. E., and Kim, K. H. (1988) Effect of tumor necrosis factor on acetyl-coenzyme A carboxylase gene expression and pre-adipocyte differentiation. Mol. Endocrinol. 2, 395-403
37. Carbó, N., Costelli, P., Tessitore, L., Bagby, G. J., López-Soriano, F. J., Baccino, F. M., and Argilés, J. M. (1994) Anti-tumour necrosis factor-α treatment interferes with changes in lipid metabolism in a cachectic tumour model. Clin. Sci. 87, 349-355
38. Flores, E. A., Bistrian, B. R., Pomposelli, J. J., Dinarello, C. A., Blackburn, G. L., and Istfan, N. W. (1989) Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukinl. J. Clin. Invest. 83, 1614-1622
39. Goodman, M. N. (1991) Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am. J. Physiol. 260, E727-E730
40. Zamir, O., Hasselgren, P. O., Kunkel, S. L., Frederick, J., Higashiguchi, T., and Fischer, J. E. (1992) Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch. Surg. 127, 170-174
41. Llovera, M., López-Soriano, F. J., and Argilés, J. M. (1993) Effects of tumour necrosis factor-α on muscle protein turnover in vivo in female rats. J. Natl. Cancer Inst. USA 85, 1334-1339
42. Garcia-Martínez, C., Agell, N., Llovera, M., López-Soriano, F. J., and Argilés, J. M. (1993) Tumour necrosis factor-α increases the ubiquitinization of rat skeletal muscle proteins. FEBS Lett. 323, 211-214
43. Nicholls, D. G. (1983) The thermogenic mechanism of brown adipose tissue. Biosci. Rep. 3, 431-441
44. Rothwell, N. J. (1993) Cytokines and thermogenesis. Int. J. Obesity 17, S98-S101
45. Blanchi, A., Bruce, J., Cooper, A. L., Childs, C., Kohli, M., Morris, I. D., Morris-Jones, P., and Rothwell, N. J. (1989) Increased brown adipose tissue activity in children with malignant disease. Horm. Metab. Res. 21, 11
46. Oudart, H., Calgari, C., Andriamampandry, M., LeMaho, Y., and Malan, A. (1995) Stimulation of brown adipose tissue activity in tumor-bearing rats. Can. J. Physiol. Pharmacol. 73, 1625-1631
47. López-Soriano, J., Argilés, J. M., and López-Soriano, F. J. (1995) Metabolic effects of tumour necrosis factor-α on rat brown adipose tissue. MoL. Cell Biochem. 143, 113-118
48. Kaplan, N. M. (1989) The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med. 149, 1514-1520
49. Björntorp, P. (1991) Metabolic implications of body fat distribution. Diabetes Care 14, 1132-1143
50. Frayn, K. N., and Coppack, S. W. (1992) Insulin resistance, adipose tissue and coronary heart disease. Clin. Sci. 82, 1-8
51. Hotamisligil, G. S., Shargill, N. S., and Spiegelman, B. M. (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259, 87-91
52. Hotamisligil, G. S., Murray, D. L., Choy, L. N., and Spiegelman, B. M. (1994) Tumor necrosis factor a inhibits signalling from the insulin receptor. Proc. Natl. Acad. Sci. USA 91, 4854-4858
53. Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., and Simsolo, R. B. (1995) The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95, 2111-2119
54. Felig, P. (1979) Starvation. In Endocrinology, Vol. 3, pp. 1927-1940, Grune & Stratton, New York
55. Stock, M. J., and Rothwell, N. J. (1986) Brown adipose tissue and the response to overfeeding. Biochem. Soc. Trans. 14, 2
56. Arbós, J., López-Soriano, F. J., Carbó, N., and Argilés, J. M. (1992) The effects of tumour necrosis factor-α (cachectin) on glucose metabolism in the rat. Mol. Cell. Biochem. 112, 53-59
57. Fargeas, M. J., Fioramonti, J., and Bueno, L. (1993) Central action of interlekin 1β on intestinal motility in rats: mediation by two mechanisms. Gastroenterology 104, 377-383
58. Plata-Salaman, C. R., and Borkoski, J. P. (1994) Chemokines/ intercrines and central regulation of feeding. Am. J. Physiol. 266, R1711-R1715
59. Schwartz, M. W., Dallman, M. F., and Woods, S. C. (1995) Hypothalamic response to starvation: implications for the study of wasting disorders. Am. J. Physiol. 269, R949-R957
60. Oliff, A., Defeo-Jones, D., Boyer, M., Martinez, D., Kiefer, D., Vuocolo, G., Wolfe, A., and Socher, S. H. (1987) Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50, 555-563
61. Dascombe, M. J., Hardwick, A., Lefeuvre, R. A., and Rothwell, N. J. (1989) Impaired effects of interleukin-1β on fever and thermogenesis in genetically obese rats. Int. J. Obesity 13, 367-373
62. Dascombe, M. J., Hardwick, A., Lefeuvre, R. A., and Rothwell, N. J. (1988) Reduced thermogenic responses to interleukin-1β in genetically obese Zucker rats. J. Physiol. 403, 41P
63. Rothwell, N. J. (1990) Central effects of CRF on metabolism and energy balance. Neurosci. Biobehav. Rev. 14, 263-271
64. Donner, C. C., Fraze, E., Chen, Y. D. Y., and Reaven, G. M. (1985) Quantitation of insulin-stimulated glucose disposal in patients with non-insulin-dependent diabetes mellitus. Diabetes 34, 831-835
65. Taylor, R., and Agius, L. (1988) The biochemistry of diabetes. Biochem. J. 250, 625-640
66. Leahy, J. L. (1990) Natural history of β-cell dysfunction in NIDDM. Diabetes Care 13, 992-1010
67. De Fronzo, R. A., Gunnarson, R., Bjorkman, O., Olsson, M., and Wahren, J. (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (type II) diabetes mellitus. J. Clin. Invest. 76, 149-155
68. Rayfield, E. J., Ault, M. J., Keusch, G. T., Brothers, M. J., Nechemias, C., and Smith, H. (1982) Infection and diabetes: the case for glucose control. Am. J. Med. 72, 439-450
69. Lang, C. H., and Dobrescu, C. (1989) Sepsis-induced changes in in vivo insulin action in diabetic rats. Am. J. Physiol. 257, E301-E308
70. Lang, C. H., Dobrescu, C., and Bagby, G. J. (1992) Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130, 43-52
71. Van der Poll, T., Romijnm, A., Endert, E., Borm, J. J. J., Buller, H. R., and Sauerwein, H. P. (1991) Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am. J. Physiol. 261, E457-E465
72. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., and Spiegelman, B. M. (1995) Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95, 2409-2415
73. Arner, P. (1996) Obesity and insulin resistance in Swedish subjects. Diabetes Metab. 13, S85-S86
74. Stephens, J. M., and Pekala, P. H. (1991) Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-α. J Biol. Chem. 266, 21839-21845
75. Pekala, P., Kawakami, W., Angus, C. W., Lane, A., and Cerami, A. (1983) Selective inhibition of synthesis for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells. Proc. Natl. Acad. Sci. USA 80, 2743-2747
76. Spiegelman, B. M., and Hotamisligil, G. S. (1993). Through thick and thin: wasting, obesity, and TNFα. Cell 73, 625-627
77. Saghizadeh, M., Ong, J. M., Garvey, W. T., Henry, R. R., and Kern, P. A. (1996) The expression of TNF α by human muscle. Relationship to insulin resistance. J. Clin. Invest. 97, 1111-1116
78. Hofmann, C., Lorenz, K., Braithwaite, S. S., Colca, J. R., Palazuk, B. J., Hotamisligil, G. S., and Spiegelman, B. M. (1994) Altered gene expression for tumor necrosis factor-a and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134, 264-270
79. Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., and Spiegelman, B. M. (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271, 665-668
80. Kennedy, G. (1953) The role of depot fat in the hypothalamic control of food intake in the rat. Proc. R. Soc. B. 140, 578-592
81. Faust, I. M. (1981) Signals from adipose tissue. In The Body Weight Regulatory System: Normal and Disturbed Mechanisms (Cioffi, L. A., James, W. P. T. and Van Itallie, T. B., eds) pp. 39-43, Raven Press, New York
82. Alemany, M. (1989) The etiologic basis for the classification of obesity. Prog. Food Nutr. Sci. 13, 45-56
83. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J. M. (1994) Positional cloning of the mouse obese gene and its human analogue. Nature (London) 372, 425-432
84. Phillips, M. S., Liu, Q., Hammond, H. A., Dugan, V. M., Hey, P. J., Caskey, C. T., and Hess, J. F. (1996) Leptin receptor missense mutation in the fatty Zucker rat. Nature Genet. 13, 18-19
85. Madej, T., Boguski, M. S., and Bryant, S. H. (1995) Threading analysis suggests that the obese gene product may be a helical cytokine. FEBS Lett. 373, 13-18
86. Hamann, A., and Matthaei, S. (1996) Regulation of energy balance by leptin. Exp. Clin. Endocrinol. Diabetes 104, 293-300
87. Frederich, R. C., Hamann, A., Anderson, S., Löllmann, B., Lowell, B. B., and Flier, J. S. (1995) Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nature Med. 1, 1311-1314
88. Frederich, R. C., Löllmann, B., Hamann, A., Napolitano-Rosen, A., Kahn, B. B., and Flier, J. S. (1995) Expression of ob mRNA and its encoded protein in rodents: impact of nutrition and obesity. J. Clin. Invest. 95, 1658-1663
89. Leroy, P., Dessolin, S., Villageois, P., Moon, B. C., Friedman, J. M., Ailhaud, G., and Dani, C. (1996) Expression of ob gene in adipose cells: regulation by insulin. J. Biol. Chem. 271, 2365-2368
90. de Vos, P., Saladin, R., Auwerx, J., and Stack, B. (1995) Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J. Biol. Chem. 270, 15958-15961
91. Grunfeld, C., Zhao, C., Fuller, J., Pollock, A., Moser, A., Friedman, J., and Feingold, K. R. (1996) Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. A role for leptin in the anorexia of infection. J. Clin. Invest. 97, 2152-2157
92. Tanaka, J., and Nomura, M. (1993) Involvement of neurons sensitive to angiotensin II in the median preoptic nucleus in the drinking response induced by angiotensin II activation of the subfornical organ in rats. Exp. Neurol. 119, 235-239
93. Remesar, X., Rafecas, I., Fernández-López, J. A., and Alemany, M. (1997) Is leptin an insulin counter-regulatory hormone? FEBS Lett. 402, 9-11
94. Sprengers, E. D., and Kluft, C. (1987) Plasminogen activator inhibitors. Blood 69, 381-387
95. Astrup, T. (1978) Fibrinolysis: an overview. In Progress in Chemical Fibrinolysis and Thrombolysis (Davidson, J. F., Rowan, R. M., Samama, M. M., and Desnoyers, P. C., eds) pp. 1-57, Raven Press, New York.
96. Vassalli, J. D., Sappini, A. P., and Belin, D. (1991) The plasminogen activator/plasmin system. J Clin. Invest. 88, 1067-1072
97. McGill, J. B., Schneider, D. J., Arfken, C. L., Lucore, C. L., and Sobel, B. E. (1994) Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 43, 104-109
98. Vague, P., Juhan-Vague, I., Chabert, V., Alessi, M. C., and Atlan, C. (1989) Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women. Metab. Clin. Exp. 38, 913-915
99. Samad, F., Yamamoto, K., and Loskutoff, D. J. (1996) Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-α and lipopolysaccharide. J. Clin. Invest. 97, 37-46
100. Sanchis, D., Balada, F., Grasa, M. M., Virgili, J., Peinado, J., Montserrat, C., Fernández-López, J. A., Remesar, X., and Alemany, M. (1996) Oleoyl-estrone induces the loss of body fat in rats. Int. J. Obesity 20, 588-594
101. Napolitano, A., Lowell, B. B., Damm, D., Leibel, R. L., Ravussin, E., Jimerson, D.C., Lesem, M. D., Van Dyke, D. C., Daly, P. A., and Chatis, P. (1994) Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass. Int. J. Obesity 18, 213-218
102. Cianflone, K., Roncari, D. A., Maslowska, M., Baldo, A., Forden, J., and Sniderman, A. D. (1994) Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 33, 9489-9495
103. Tao, Y., Cianflone, K., Sniderman, A. D., Colby-Germinario, S. P., and Germinario, R. J. (1997) Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line. Biochim. Biophys. Acta 1344, 221-229
104. Cianflone, K., Maslowska, M., and Sniderman, A. (1995) The acylation stimulating protein-adipsin system. Int. J. Obesity 19, S34-S38
105. Hu, E., Liang, P., and Spiegelman, B. M. (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271, 10697-10703
106. Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., and Lodish, H. F. (1995) A novel serum protein similar to Clq, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746-26749
107. Spiegelman, B. M., and Flier, J. S. (1996) Adipogenesis and obesity: rounding out the big picture. Cell 87, 377-389